tamoxifen

You have access
Cholesterol Depletion Modulates Drug Resistance Pathways to Sensitize Resistant Breast Cancer Cells to Tamoxifen
GABRIELLA BIANCA HENRIQUES PALMA and MANDEEP KAUR

Anticancer Research January 2022, 42 (1) 565-579; DOI: https://doi.org/10.21873/anticanres.15514
You have access
Combinatorial Cytotoxic Effects of 2,3-Dichloro-5,8-dimethoxy-1,4-naphthoquinone and 4-hydroxytamoxifen in Triple-negative Breast Cancer Cell Lines
ANASTASIA G.J. ROBINSON, YASMINE M. KANAAN and ROBERT L. COPELAND

Anticancer Research December 2020, 40 (12) 6623-6635; DOI: https://doi.org/10.21873/anticanres.14687
You have access
Ginseng Seed Oil Inhibits the Growth of Estrogen Receptor-positive Breast Cancer Cells
TAE HUN KIM, SANG-CHUL KWON, JEONG NAM KIM, JI-HYE YOON and SUNG-GOOK CHO

Anticancer Research August 2020, 40 (8) 4529-4535; DOI: https://doi.org/10.21873/anticanres.14458
You have access
Tamoxifen Suppresses the Growth of Malignant Pleural Mesothelioma Cells
CORMAC J. JENNINGS, NAJIHAH ZAINAL, IZYAN M. M. DAHLAN, ELAINE W. KAY, BRIAN J. HARVEY and WARREN THOMAS

Anticancer Research November 2016, 36 (11) 5905-5913;
You have access
Co-targeting ER and HER Family Receptors Induces Apoptosis in HER2-normal or Overexpressing Breast Cancer Models
ASHOK K. CHAKRABORTY, RANEE MEHRA and MICHAEL P. DIGIOVANNA

Anticancer Research March 2015, 35 (3) 1243-1250;
You have access
Continuous Tamoxifen and Dose-dense Temozolomide in Recurrent Glioblastoma
ANDREA DI CRISTOFORI, GIORGIO CARRABBA, GIORDANO LANFRANCHI, CLAUDIA MENGHETTI, PAOLO RAMPINI and MANUELA CAROLI

Anticancer Research August 2013, 33 (8) 3383-3389;
You have access
Pharmacokinetic Drug Interactions between Ondansetron and Tamoxifen in Female Sprague-Dawley Rats with DMBA-induced Mammary Tumor
SI HYUNG YANG, JUNG HWA SUH, MYUNG GULL LEE and SO HEE KIM

Anticancer Research February 2013, 33 (2) 521-528;

Main menu

User menu

Search

tamoxifen